Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Articles in E-pub version are posted online ahead of regular printed publication.

Original Article

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo

Received March 3, 2023 Accepted March 21, 2023

DOI: https://doi.org/10.3350/cmh.2023.0089 [Accepted]

View: 243 Download: 25

Review

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Japanese perspective

Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi

Received March 12, 2023 Accepted March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0102 [Accepted]

View: 128 Download: 19

Editorial

Challenges in Translating Clinical Practice Guidelines into Real-Life Practice for the management of hepatocellular carcinoma in Taiwan

San-Chi Chen

Received March 11, 2023 Accepted March 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101 [Accepted]

View: 83 Download: 4

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

Philipp Kasper, Münevver Demir, Hans-Michael Steffen

Received February 15, 2023 Accepted March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0059 [Accepted]

View: 62 Download: 4

Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap

Shen-Yung Wang

Received February 28, 2023 Accepted March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0082 [Accepted]

View: 64 Download: 4

Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?

Joo Hyun Oh, Dong Hyun Sinn

Received February 10, 2023 Accepted March 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0054 [Accepted]

View: 49 Download: 1

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma

Do Young Kim

Received March 15, 2023 Accepted March 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0107 [Accepted]

View: 73 Download: 3

Review

Acute -on- Chronic liver failure – Terminology, Mechanisms and Management

Vinay Kumar BR, Shiv Kumar Sarin

Received April 16, 2022 Accepted February 25, 2023

DOI: https://doi.org/10.3350/cmh.2022.0103 [Accepted]

View: 139 Download: 25

Editorial

The clinical management of HCC in China: progresses and challenges

Shan Shan, Jidong Jia

Received February 28, 2023 Accepted March 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0077 [Accepted]

View: 87 Download: 10

What should be done to reduce the discrepancy between guidelines and real-life practice for HCC in Korea?

Min Kyung Park, Yoon Jun Kim

Received February 28, 2023 Accepted March 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0080 [Accepted]

View: 61 Download: 0

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease

Ji-Won Park, Ki Tae Suk

Received March 1, 2023 Accepted March 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0085 [Accepted]

View: 82 Download: 12

Management of Hepatocellular Carcinoma in China: Seeking Common Grounds While Reserving Differences

Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen

Received March 14, 2023 Accepted March 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0106 [Accepted]

View: 106 Download: 11

The current trends in the health burden of primary liver cancer across the globe

Peter Konyn, Aijaz Ahmed, Donghee Kim

Received March 4, 2023 Accepted March 11, 2023

DOI: https://doi.org/10.3350/cmh.2023.0092 [Accepted]

View: 110 Download: 6

Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?

Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang

Received February 23, 2023 Accepted March 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0069 [Accepted]

View: 97 Download: 4

Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology

Eileen Laurel Yoon, Dae Won Jun

Received March 1, 2023 Accepted March 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0086 [Accepted]

View: 100 Download: 11

Implications of comorbidities in nonalcoholic fatty liver disease

Sherlot Juan Song, Vincent Wai-Sun Wong

Received February 16, 2023 Accepted March 11, 2023

DOI: https://doi.org/10.3350/cmh.2023.0066 [Accepted]

View: 112 Download: 11

Review

Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm

Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao

Received November 26, 2022 Accepted March 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0420 [Accepted]

View: 125 Download: 22

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Received March 9, 2023 Accepted March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0099 [Accepted]

View: 187 Download: 29

Editorial

The prime time for management of hepatocellular carcinoma in Hong Kong

Landon L. Chan, Stephen L. Chan

Received March 7, 2023 Accepted March 8, 2023

DOI: https://doi.org/10.3350/cmh.2023.0094 [Accepted]

View: 109 Download: 5

The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise

Moon Haeng Hur, Jeong-Hoon Lee

Received February 28, 2023 Accepted March 7, 2023

DOI: https://doi.org/10.3350/cmh.2023.0079 [Accepted]

View: 73 Download: 8

Lean vs. obese NAFLD, two phenotypes of NAFLD: look the same but different or vice versa?

Ho Soo Chun, Minjong Lee

Received February 15, 2023 Accepted March 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0061 [Accepted]

View: 85 Download: 12

Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors?

Heejoon Jang, Won Kim

Received March 2, 2023 Accepted March 4, 2023

DOI: https://doi.org/10.3350/cmh.2023.0088 [Accepted]

View: 140 Download: 12

The latest global burden of liver cancer: A past and present threat

Joo Hyun Oh, Dae Won Jun

Received February 23, 2023 Accepted March 4, 2023

DOI: https://doi.org/10.3350/cmh.2023.0070 [Accepted]

View: 95 Download: 11

Review

Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy

Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka

Received December 2, 2022 Accepted March 7, 2023

DOI: https://doi.org/10.3350/cmh.2022.0434 [Accepted]

View: 222 Download: 39

Original Article

Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis

Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim

Received October 22, 2022 Accepted March 6, 2023

DOI: https://doi.org/10.3350/cmh.2022.0330 [Accepted]

View: 175 Download: 18

Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing

Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong

Received October 28, 2022 Accepted March 1, 2023

DOI: https://doi.org/10.3350/cmh.2022.0345 [Accepted]

View: 154 Download: 26

Review

A decade of liver organoids: Advancements in disease modeling

Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan

Received November 29, 2022 Accepted February 28, 2023

DOI: https://doi.org/10.3350/cmh.2022.0428 [Accepted]

View: 245 Download: 52

Editorial

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

Byeong Geun Song, Dong Hyun Sinn

Received January 5, 2023 Accepted February 27, 2023

DOI: https://doi.org/10.3350/cmh.2023.0058 [Accepted]

View: 131 Download: 7

The growing burden of non-alcoholic fatty liver disease on mortality

Ju-Yeon Cho, Won Sohn

Received February 28, 2023 Accepted March 2, 2023

DOI: https://doi.org/10.3350/cmh.2023.0084 [Accepted]

View: 125 Download: 10

Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future

Kee-Huat Chuah, Wah-Kheong Chan

Received February 15, 2023 Accepted February 23, 2023

DOI: https://doi.org/10.3350/cmh.2023.0062 [Accepted]

View: 120 Download: 10

The Independent Effect of Exercise on Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review

Young-Joo Jin

Received February 10, 2023 Accepted February 22, 2023

DOI: https://doi.org/10.3350/cmh.2023.0055 [Accepted]

View: 1441 Download: 33

Snapshot

Systemic therapy in advanced hepatocellular carcinoma

Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang

Received February 10, 2023 Accepted February 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0051 [Accepted]

View: 191 Download: 44

Original Article

Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions

Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun

Received October 21, 2022 Accepted February 16, 2023

DOI: https://doi.org/10.3350/cmh.2022.0327 [Accepted]

View: 360 Download: 48

Review

Acute hepatitis C virus infection: clinical update and remaining challenges

Chen-Hua Liu, Jia-Horng Kao

Received October 30, 2022 Accepted February 16, 2023

DOI: https://doi.org/10.3350/cmh.2022.0349 [Accepted]

View: 369 Download: 89

Correspondance

Correspondence on Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"

Jeong-Ju Yoo, Sang Gyune Kim

Received February 6, 2023 Accepted February 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0044 [Accepted]

View: 108 Download: 6

Review

Development of hepatocellular carcinoma in untreated and treated patients with chronic hepatitis B virus infection

Chih-Lin Lin, Jia-Horng Kao

Received October 31, 2022 Accepted February 12, 2023

DOI: https://doi.org/10.3350/cmh.2022.0342 [Accepted]

View: 379 Download: 73

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity

Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi

Received November 9, 2022 Accepted February 9, 2023

DOI: https://doi.org/10.3350/cmh.2022.0391 [Accepted]

View: 342 Download: 81

Editorial

Non-invasive biomarkers of liver fibrosis in NAFLD

Basheer M, Naffaa ME, Assy N

Received February 6, 2023 Accepted February 8, 2023

DOI: https://doi.org/10.3350/cmh.2023.0045 [Accepted]

View: 195 Download: 39

Original Article

Factors Associated with Unrecognized Cirrhosis in Patients with Hepatocellular Carcinoma

Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang

Received December 15, 2022 Accepted January 29, 2023

DOI: https://doi.org/10.3350/cmh.2022.0450 [Accepted]

View: 394 Download: 35

Review

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

Shang-Chin Huang, Chun-Jen Liu

Received November 27, 2022 Accepted January 5, 2023

DOI: https://doi.org/10.3350/cmh.2022.0422 [Epub ahead of print]

View: 523 Download: 120

Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications

Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz

Received November 28, 2022 Accepted January 31, 2023

DOI: https://doi.org/10.3350/cmh.2022.0425 [Accepted]

View: 336 Download: 39

Letter to the Editor

Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"

Chia-Ming Chu, Yun-Fan Liaw.

Received January 19, 2023 Accepted January 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0018 [Accepted]

View: 213 Download: 22

Review

Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region

Do-Young KIM, Bao Nguyen TOAN, Chee-Kiat TAN, Irsan HASAN, Lyana SETIAWAN, Ming-Lung YU, Namiki IZUMI, Nguyen Nguyen HUYEN, Pierce Kah-Hoe CHOW, Rosmawati MOHAMED, Stephen Lam CHAN, Tawesak TANWANDEE, Teng-Yu LEE, Thi Thanh Nguyen HAI, Tian YANG, Woo-Chang LEE, Henry Lik Yuen CHAN

Received July 19, 2022 Accepted January 25, 2023

DOI: https://doi.org/10.3350/cmh.2022.0212 [Accepted]

View: 730 Download: 170

Clinical practice guidelines and real-life practice for hepatocellular carcinoma in Taiwan

Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu

Received November 26, 2023 Accepted January 24, 2023

DOI: https://doi.org/10.3350/cmh.2022.0421 [Accepted]

View: 640 Download: 121

The role of different viral biomarkers on the management of chronic hepatitis B For special issue ‘Challenging issues in the treatment of viral hepatitis’

Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen

Received December 14, 2022 Accepted January 15, 2023

DOI: https://doi.org/10.3350/cmh.2022.0448 [Accepted]

View: 433 Download: 75

Original Article

The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase

Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim

Received October 19, 2022 Accepted January 3, 2023

DOI: https://doi.org/10.3350/cmh.2022.0322 [Accepted]

View: 442 Download: 51

Review

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi

Received November 16, 2022 Accepted January 1, 2023

DOI: https://doi.org/10.3350/cmh.2022.0404 [Epub ahead of print]

View: 468 Download: 51

Original Article

Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences, 1990-2019: a DALYs-based analysis of the Global Burden of Disease 2019 study

Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith

Received October 17, 2022 Accepted December 27, 2022

DOI: https://doi.org/10.3350/cmh.2022.0316 [Accepted]

View: 722 Download: 92 Citation: 1

Review

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective

Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen

Received November 14, 2022 Accepted December 23, 2022

DOI: https://doi.org/10.3350/cmh.2022.0399 [Epub ahead of print]

View: 665 Download: 108

Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective

Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao

Received November 15, 2022 Accepted December 20, 2022

DOI: https://doi.org/10.3350/cmh.2022.0402 [Accepted]

View: 803 Download: 174

Original Article

Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease

Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi

Received July 14, 2022 Accepted November 16, 2022

DOI: https://doi.org/10.3350/cmh.2022.0205 [Epub ahead of print]

View: 795 Download: 56

Viewed By 5610	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3576	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3249	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2702	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2607	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology

Cited By 88	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 33	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Ahead-of-print